Suh is a director as well as a principal investigator in imaging development projects of medical convergence research institute at Yonsei University.

Suh took the residency 4-years training and 2 years fellowship in department of Radiology, Severance Hospital, Yonsei University.

He proved the concept of targeted cancer molecular imaging using high sensitive antibody conjugated magnetic nanoparticle agents.

He could improve the sensitivity for the detection of a tumor of very small size and then revealed the possibility of personalized therapy.

Suh is a director as well as a principal investigator in imaging development projects of medical convergence research institute in Yonsei university and Korea's Frontier Research Scientist, named by the Korean Academy of Science and Technology (KAST) 2011.